Logo image of 1HOLX.MI

HOLOGIC INC (1HOLX.MI) Stock Fundamental Analysis

BIT:1HOLX - Euronext Milan - US4364401012 - Common Stock - Currency: EUR

56.5  -0.5 (-0.88%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to 1HOLX. 1HOLX was compared to 59 industry peers in the Health Care Equipment & Supplies industry. 1HOLX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1HOLX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

1HOLX had positive earnings in the past year.
In the past year 1HOLX had a positive cash flow from operations.
1HOLX had positive earnings in each of the past 5 years.
In the past 5 years 1HOLX always reported a positive cash flow from operatings.
1HOLX.MI Yearly Net Income VS EBIT VS OCF VS FCF1HOLX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

1HOLX's Return On Assets of 6.51% is fine compared to the rest of the industry. 1HOLX outperforms 76.27% of its industry peers.
Looking at the Return On Equity, with a value of 12.05%, 1HOLX is in the better half of the industry, outperforming 77.97% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.33%, 1HOLX belongs to the best of the industry, outperforming 84.75% of the companies in the same industry.
1HOLX had an Average Return On Invested Capital over the past 3 years of 11.66%. This is above the industry average of 8.57%.
Industry RankSector Rank
ROA 6.51%
ROE 12.05%
ROIC 10.33%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1HOLX.MI Yearly ROA, ROE, ROIC1HOLX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

1HOLX has a Profit Margin of 13.83%. This is in the better half of the industry: 1HOLX outperforms 79.66% of its industry peers.
In the last couple of years the Profit Margin of 1HOLX has declined.
Looking at the Operating Margin, with a value of 24.43%, 1HOLX belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
1HOLX's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 56.44%, 1HOLX perfoms like the industry average, outperforming 50.85% of the companies in the same industry.
In the last couple of years the Gross Margin of 1HOLX has grown nicely.
Industry RankSector Rank
OM 24.43%
PM (TTM) 13.83%
GM 56.44%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
1HOLX.MI Yearly Profit, Operating, Gross Margins1HOLX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1HOLX is still creating some value.
1HOLX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 1HOLX has less shares outstanding
1HOLX has a better debt/assets ratio than last year.
1HOLX.MI Yearly Shares Outstanding1HOLX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
1HOLX.MI Yearly Total Debt VS Total Assets1HOLX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.87 indicates that 1HOLX is not in any danger for bankruptcy at the moment.
1HOLX has a Altman-Z score of 3.87. This is in the better half of the industry: 1HOLX outperforms 74.58% of its industry peers.
1HOLX has a debt to FCF ratio of 2.61. This is a good value and a sign of high solvency as 1HOLX would need 2.61 years to pay back of all of its debts.
The Debt to FCF ratio of 1HOLX (2.61) is better than 77.97% of its industry peers.
A Debt/Equity ratio of 0.54 indicates that 1HOLX is somewhat dependend on debt financing.
1HOLX has a Debt to Equity ratio of 0.54. This is in the lower half of the industry: 1HOLX underperforms 61.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.61
Altman-Z 3.87
ROIC/WACC1.25
WACC8.27%
1HOLX.MI Yearly LT Debt VS Equity VS FCF1HOLX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 3.24 indicates that 1HOLX has no problem at all paying its short term obligations.
1HOLX's Current ratio of 3.24 is amongst the best of the industry. 1HOLX outperforms 81.36% of its industry peers.
1HOLX has a Quick Ratio of 2.52. This indicates that 1HOLX is financially healthy and has no problem in meeting its short term obligations.
1HOLX has a Quick ratio of 2.52. This is amongst the best in the industry. 1HOLX outperforms 81.36% of its industry peers.
Industry RankSector Rank
Current Ratio 3.24
Quick Ratio 2.52
1HOLX.MI Yearly Current Assets VS Current Liabilites1HOLX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

4

3. Growth

3.1 Past

1HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.83%.
Measured over the past years, 1HOLX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.83% on average per year.
Looking at the last year, 1HOLX shows a small growth in Revenue. The Revenue has grown by 1.66% in the last year.
1HOLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.66% yearly.
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%

3.2 Future

The Earnings Per Share is expected to grow by 5.71% on average over the next years.
The Revenue is expected to grow by 4.75% on average over the next years.
EPS Next Y4.52%
EPS Next 2Y6.03%
EPS Next 3Y7.34%
EPS Next 5Y5.71%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.78%
Revenue Next 5Y4.75%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1HOLX.MI Yearly Revenue VS Estimates1HOLX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
1HOLX.MI Yearly EPS VS Estimates1HOLX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.69, 1HOLX is valued correctly.
86.44% of the companies in the same industry are more expensive than 1HOLX, based on the Price/Earnings ratio.
1HOLX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 14.14, which indicates a correct valuation of 1HOLX.
Based on the Price/Forward Earnings ratio, 1HOLX is valued a bit cheaper than 76.27% of the companies in the same industry.
1HOLX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 15.69
Fwd PE 14.14
1HOLX.MI Price Earnings VS Forward Price Earnings1HOLX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1HOLX is valued cheaper than 81.36% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1HOLX is valued cheaper than 91.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.9
EV/EBITDA 11.84
1HOLX.MI Per share data1HOLX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1HOLX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1HOLX may justify a higher PE ratio.
PEG (NY)3.47
PEG (5Y)1.45
EPS Next 2Y6.03%
EPS Next 3Y7.34%

More info and screens

0

5. Dividend

5.1 Amount

1HOLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOLOGIC INC

BIT:1HOLX (6/13/2025, 7:00:00 PM)

56.5

-0.5 (-0.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners102.68%
Inst Owner ChangeN/A
Ins Owners0.78%
Ins Owner ChangeN/A
Market Cap12.59B
Analysts70
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.62%
Min EPS beat(2)-0.63%
Max EPS beat(2)-0.62%
EPS beat(4)1
Avg EPS beat(4)-0.3%
Min EPS beat(4)-2.26%
Max EPS beat(4)2.31%
EPS beat(8)5
Avg EPS beat(8)1.16%
EPS beat(12)9
Avg EPS beat(12)8.52%
EPS beat(16)13
Avg EPS beat(16)16.77%
Revenue beat(2)0
Avg Revenue beat(2)-1.83%
Min Revenue beat(2)-2.22%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.22%
Max Revenue beat(4)-0.83%
Revenue beat(8)2
Avg Revenue beat(8)-0.77%
Revenue beat(12)6
Avg Revenue beat(12)1.68%
Revenue beat(16)10
Avg Revenue beat(16)5.33%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.69
Fwd PE 14.14
P/S 3.59
P/FCF 14.9
P/OCF 12.77
P/B 3.13
P/tB 45.04
EV/EBITDA 11.84
EPS(TTM)3.6
EY6.37%
EPS(NY)4
Fwd EY7.07%
FCF(TTM)3.79
FCFY6.71%
OCF(TTM)4.42
OCFY7.83%
SpS15.74
BVpS18.06
TBVpS1.25
PEG (NY)3.47
PEG (5Y)1.45
Profitability
Industry RankSector Rank
ROA 6.51%
ROE 12.05%
ROCE 13.02%
ROIC 10.33%
ROICexc 13.15%
ROICexgc 47.7%
OM 24.43%
PM (TTM) 13.83%
GM 56.44%
FCFM 24.09%
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score8
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 2.61
Debt/EBITDA 1.93
Cap/Depr 54.33%
Cap/Sales 4.01%
Interest Coverage 250
Cash Conversion 88.34%
Profit Quality 174.26%
Current Ratio 3.24
Quick Ratio 2.52
Altman-Z 3.87
F-Score8
WACC8.27%
ROIC/WACC1.25
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)7.83%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%0%
EPS Next Y4.52%
EPS Next 2Y6.03%
EPS Next 3Y7.34%
EPS Next 5Y5.71%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%-1.23%
Revenue Next Year1.24%
Revenue Next 2Y3.06%
Revenue Next 3Y3.78%
Revenue Next 5Y4.75%
EBIT growth 1Y11.01%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year13.56%
EBIT Next 3Y8.09%
EBIT Next 5Y6.92%
FCF growth 1Y15.42%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y17.99%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%